Qld company’s anti-inflammatory drug being trialled in COVID-19 and motor neurone diseaseJanelle MilesThe Courier-MailThu, 15 April 2021 8:03PMPremiumPremiumSubscribers with digital access can view this article.Already a subscriber?Login here.